Drug pricing has been one of the central issues of the 2016 presidential campaign. There is currently a whirlwind of negative public sentiment swirling around controversial pricing practices of companies likeValeant Pharmaceuticals Intl Inc VRX 1.09%, Mallinckrodt PLC MNK 2.32% and Mylan NV MYL 3.24%.

With the election only about a month away, there has probably never been a worse time for a drug company to raise prices. But as the tweet below by @AndyBiotech shows, Ariad Pharmaceuticals, Inc. ARIA 6.16% certainly doesn’t seem to be deterred.

According to the tweet, Ariad has upped the price of its cancer drug Iclusig by 39 percent in 2016. While cancer patients are paying more for Iclusig, Ariad’s share price has more than doubled in 2016, up 121.3 percent.

Democratic presidential nominee Hillary Clinton has been very clear about targeting drug companies that can’t justify their price hikes.

“It’s…

Click here to continue reading

Want to learn more about how to profit off the stock market? Or maybe you just want to be able to look sophisticated in front of your coworkers when they ask you what you are reading on your Kindle, and you’d prefer to tell them “Oh, I’m just reading a book about stock market analysis,” rather than the usual “Oh, I’m just looking at pics of my ex-girlfriend on Facebook.” For these reasons and more, check out my book, Beating Wall Street with Common Sense. I don’t have a degree in finance; I have a degree in neuroscience. You don’t have to predict what stocks will do if you can predict what traders will do and be one step ahead of them. I made a 400% return in the stock market over five years using only basic principles of psychology and common sense. Beating Wall Street with Common Sense is now available on Amazon, and tradingcommonsense.com is always available on your local internet!